Skip to main content
Log in

Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case–control study

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate whether recent systemic anti-inflammatory agents (AIAs) exposure in patients with sore throat managed with or without antibiotic therapy influenced the risk of peritonsillar abscess (PTA). We conducted a multicenter case–control study in 13 French university hospitals in 2009–2012 comparing patients admitted with PTA to matched controls: patients with sore throat but without PTA who were followed up for 10 days after visiting their primary-care physician. In the multivariate stepwise logistic regression model comparing 120 cases with PTA to 143 controls, factors significantly associated with PTA were male gender (odds ratio [OR], 2.0; p = 0.03), smoking (OR, 2.0; p = 0.03), and prior self-medication with systemic AIAs (OR, 3.5; p = 0.01). Topical treatment was associated with significant protection against PTA (OR, 0.3; p < 0.001). In conclusion, self-medication with systemic AIAs appears to be an independent factor associated with the occurrence of PTA. This is an important message as non-steroidal AIAs access is favored by their over-counter availability in pharmacies. This finding must be interpreted with caution due to the study design and a prospective, randomized study is needed to substantiate these possible causal risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mazur E, Czerwińska E, Korona-Głowniak I, Grochowalska A, Kozioł-Montewka M (2015) Epidemiology, clinical history and microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis 34:549–554

    Article  CAS  PubMed  Google Scholar 

  2. Mitchell-Innes A, Abdelrahim A, Muzaffar J, Douglas J, Walton J, Hardman J, Jackson L, Mehanna H, Nankivell P, Sekhon P, Siddiq S, Mayberry T, Deutsch C, Jani P, Eladawy I, Smith C, McBride G, Abdalla H, Boyle S, Hope N, Irwin L, Toner F, Scally C, McShea J, Neeson D, Can N, Natt R, Leonard C, Hampton S, Cassidy S, Dick D, Hamilton L, Hodgkinson A, Logan T, Sharma N, McDermott A, Abdelrahim A, Oluwole M, Gill N, Kulendra K, Menon E, Rajput S, Navaratnam A, Pace-Balzan A, Cresswell M, Maheshwar A, Cresner R, Latchman M, McClenaghan F, Adams M, Leyden P, Moore A, Counter P, Blanchford H, Lester S, Ellis M, Maw J, Gungadeen A, Meikle D, Jessett A, Lisseter R, Shillitoe H, Thompson P, Jackson L, Galm T, Duff H, Barr J, Chevretton E, Oswald N, Fisher E, Jiang L, Vijendren A, Salam M, Alder G, Bowmer C, Veer V, Dimitriadis P, Kothari P, Alabim A, Carstea A, Doke T, Munroe-Gray T, Mayberry T, Spinou C, Douglas J, Manjaly J, Albeyatti A, Tatla T, Ferreira-Martins J, Segar H, Watson N, Golding-Wood D, Medhi F, Obeid N, Young E, Mehanna H, Benning C, Danino J, Rakhra G, Ziyara R, Kanona H, Eweiss A, Akuji N, Muzaffar J, Lee P, Ronan N, Flanagan P, Fussey J, Uppal H, Ahmed N, Natalwala I, Wong K, Hampton T, Das P, Coombes S, Crabtree F, Siddiq S, Jeon H, Qayyum U, Walton J, Ward M, Brockbank M, Mitchell-Innes A, Bowyer D, Campbell C, Holmes E, Jackowiak M, Osborne M, Patel S, Takhar A, Harris R, Burns Y, English E, Goh S, Mutty P, Naik R, Tetlow H, van Gijn D, Whitcroft K, Cartilage D, Yelnoorkar S, Cocks H, Abou-Nader L, Akram H, Milev S, Ritchie C, Bola S, Powles J, Maskell S, Cheang P, Chivers G, Langton-Hewer C, Fox H, Owens D, Sanyaolu L, Karamchandani D, Dezso A, Fong J, Jackson E, Sinha M, Smith M, Fahmy F, Mitchell S, Porter M, Bowles P, Harries M, Timms J (2016) National prospective cohort study of peritonsillar abscess management and outcomes: the Multicentre Audit of Quinsies study. ENT Trainee Research Collaborative – West Midlands. J Laryngol Otol 130:768–776

    Article  Google Scholar 

  3. Pinaud V, Ballereau F, Corvec S, Ferron C, Bordure P, Caillon J, Reynaud A, Asseray N, Potel G, Lepelletier D (2009) Prior use of anti-inflammatory and antibiotic drugs in patients hospitalized for peritonsillar abscess. Med Mal Infect 39:886–890

    Article  CAS  PubMed  Google Scholar 

  4. Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Asseray N, Ballereau F, Caillon J, Ferron C, Righini C, Batard E, Potel G; French PTA Study Group (2016) Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals. Eur J Clin Microbiol Infect Dis 35:867–873

    Article  CAS  PubMed  Google Scholar 

  5. McIsaac WJ, Goel V, To T, Low DE (2000) The validity of a sore throat score in family practice. CMAJ 163:811–815

    CAS  PubMed  PubMed Central  Google Scholar 

  6. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499

    Article  Google Scholar 

  7. Ong YK, Goh YH, Lee YL (2004) Peritonsillar infections: local experience. Singapore Med J 45:105–109

    CAS  PubMed  Google Scholar 

  8. Klug TE, Rusan M, Clemmensen KK, Fuursted K, Ovesen T (2013) Smoking promotes peritonsillar abscess. Eur Arch Otorhinolaryngol 270:3163–3167

    Article  PubMed  Google Scholar 

  9. Powell J, Powell EL, Conroy K, Hopkins C, Moor JW, Wilson JA (2013) Throat-related quality of life in peritonsillar abscess sufferers: application of the adult tonsil outcome inventory. J Laryngol Otol 127:1190–1193

    Article  CAS  PubMed  Google Scholar 

  10. Leroy S, Marc E, Bavoux F, Tréluyer JM, Gendrel D, Bréart G, Pons G, Chalumeau M (2010) Hospitalization for severe bacterial infections in children after exposure to NSAIDs: a prospective adverse drug reaction reporting study. Clin Drug Investig 30:179–185

    Article  CAS  PubMed  Google Scholar 

  11. Mikaeloff Y, Kezouh A, Suissa S (2008) Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol 65:203–209

    Article  PubMed  Google Scholar 

  12. Aronoff DM, Bloch KC (2003) Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 82:225–235

    CAS  Google Scholar 

  13. Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA (2001) Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107:1108–1115

    Article  CAS  PubMed  Google Scholar 

  14. Weng TC, Chen CC, Toh HS, Tang HJ (2011) Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect 44:418–423

    Article  CAS  PubMed  Google Scholar 

  15. Cheung EV, Tidball JG (2003) Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use. Inflamm Res 52:170–176

    Article  CAS  PubMed  Google Scholar 

  16. Giagoudakis G, Markantonis SL (2005) Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy 25:18–25

    Article  CAS  PubMed  Google Scholar 

  17. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS (1992) Selection of controls in case–control studies. II. Types of controls. Am J Epidemiol 135:1029–1041

    CAS  PubMed  Google Scholar 

  18. Kalton G, Piesse A (2007) Survey research methods in evaluation and case–control studies. Stat Med 26:1675–1687

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Line Happi-Djeukou and Olivier Boutin for their contribution to the data collection and for contacting the primary-care physicians who enrolled the controls. We thank Tanguy Roman for his contribution to building the electronic database.

Author contributions

Conceived and designed the study: DL, NA, FB, JC, CF, GP.

Performed the monitoring of the study: DL, VP, NA, CF, CR, GP.

Analyzed the data: DL, CB.

Wrote and validated the final version of the paper: DL, VP, PLC, CB, NA, JC, CF, EB, GP.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to D. Lepelletier.

Ethics declarations

Ethical statement

We declare that compliance with ethical standards was followed during the study period.

Funding

No specific funding has been received.

Conflict of interest

The authors have declared that no potential conflict of interest exists.

Ethical approval

Approval was obtained from the Ethic Committee of the Nantes Clinical Research Directory.

Informed consent

Written informed consent was obtained from each hospitalized patient with peritonsillar abscess.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lepelletier, D., Pinaud, V., Le Conte, P. et al. Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case–control study. Eur J Clin Microbiol Infect Dis 36, 57–63 (2017). https://doi.org/10.1007/s10096-016-2770-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-016-2770-1

Keywords

Navigation